A. ERTÜRK Et Al. , "The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive," APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754) , pp.654-655, 2013
ERTÜRK, A. Et Al. 2013. The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive. APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754) , 654-655.
ERTÜRK, A., AKDOĞAN, R. A., PARLAK, E., CUMHUR CÜRE, M., CÜRE, E., PARLAK, M., ... ÖZTÜRK, Ç.(2013). The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive . APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754) (pp.654-655).
ERTÜRK, AYŞE Et Al. "The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive," APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754), 2013
ERTÜRK, AYŞE Et Al. "The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive." APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754) , pp.654-655, 2013
ERTÜRK, A. Et Al. (2013) . "The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive." APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754) , pp.654-655.
@conferencepaper{conferencepaper, author={AYŞE ERTÜRK Et Al. }, title={The evaluation of the dose modified entacavir treatment in patients with chronic hepatitis B who are antiviral naive}, congress name={APASL Liver Week (Hepatol Int (2013) 7 (Suppl 1):S1–S754)}, city={}, country={}, year={2013}, pages={654-655} }